Oral: Paxil® CR
Paxil®
7th largest pharmaceutical product in the world
2001 revenues of $2.7 billion
Paxil® CR
GSK to launch by end of April 2002
New Geomatrix™ formulation: multi-layered tablet controlling drug dissolution and absorption
Patent protection to 2012
FDA approved for depression & panic disorder
Phase III PMDD: launch anticipated 2003
Potential for significant royalty flow